Poster
No. |
Presenter |
Title |
| P-01 |
Shinichiro
Hattori
[Kumamoto Univ.] |
The
water extract of Piper sarmentosum Roxb. potently inhibits early stage
of HIV-1 infection |
| P-02 |
Kouki
Matsuda
[Kumamoto Univ.] |
Inhibition of
HIV-1 entry by a tricyclic coumarin GUT-70 |
| P-03 |
Ryusho
Kariya
[Kumamoto Univ.] |
HAMLET and BAMLET
induce cell death of Primary Effusion Lymphoma |
| P-04 |
Eriko
Kudo
[Kumamoto Univ.] |
HIV-1 latent
infection induces IκB-α stabilization via HIV-1 restriction factor
COMMD1. |
| P-05
O-3A-27 |
Michihiro
Hashimoto
[Kumamoto Univ.] |
Nef-induced activation
of macrophages is mediated by TAK1 and macropinocytosis |
| P-06 |
Farzana
Bhuyan
[Kumamoto Univ.] |
M-Sec mediates
the tunneling nanotube-promoting activity of HIV-1 in macrophages |
| P-07
O-3A-26 |
Hesham
E. Nasser
[Kumamoto Univ.] |
Phenotypic characterization
of fibrocytes, the recently identified HIV-1 host cells |
| P-08 |
Ryota
Koba
[Kumamoto Univ.] |
Feline TRIM25
interferes with the late stage of feline leukemia virus replication |
| P-09
O-3B-36 |
Kazuaki
Monde
[Kumamoto Univ.] |
Intrinsic interference
between human endogenous retrovirus and HIV-1. |
| P-10 |
Yoshika
Egami
[Kumamoto Univ.] |
Construction
of neutralizing antibody fragment against V3 with a broad cross-reactivity |
| |
Muntasir
Alam
[Kumamoto Univ.] |
Mutations in
gp41 that confer resistance to fusion inhibitors enhance the neutralization
sensitivity to antibodies against both gp41 and gp120 |
| P-12 |
Yasuhiro
Maruta
[Kumamoto Univ.] |
Mechanism of
post-attachment neutralization of single-chain variable fragment (scFv)
from anti-V3 monoclonal antibody against HIV-1 |
| P-14 |
Kazuki
Tanaka
[Kumamoto Univ.] |
Potent neutralizing
activity of small antibody fragments targeting CD4i (CD4-induced)
epitope |
| P-15 |
Yu Irahara
[Tokyo Medical and Dental Univ.] |
A new type of
small CD4 mimic molecules targeting an HIV envelope protein gp120 |
| P-16 |
Misato
Kotani
[Tokyo Medical and Dental Univ.] |
Structure-activity
relationship studies of CD4 mimic molecules |
| P-18 |
Yuko
Yamada
[Keio Univ. / Tokyo Medical and Dental Univ.] |
A CD4 mimic as
an HIV entry inhibitor: Pharmacokinetics |
| P-19 |
Xuechao
Zhao
[Nankai Univ., China] |
The role of human
immunodeficiency virus envelope during mother-to-infant transmission |
| P-20
O-3B-29
|
Samatchaya
Boonchawalit
[Kumamoto Univ. / NIID] |
Impact of maraviroc
(MVC)-resistant mutations in the C1 and C4 regions of gp120 on sensitivity
to antibody-mediated neutralization |
| P-21 |
Yusuke
Nakano
[Kyoto Univ.] |
Influence of
CCR5 forms on the interaction of HIV-1 envelop glycoprotein gp120 |
| P-23
O-3B-30 |
Hironori
Hayashi
[NCGM] |
Dimerization
of HIV-1 Protease Occurs through Two Steps, Which Relates to the Mechanism
of Protease Dimerization Inhibition by Darunavir |
| P-24
O-3A-18 |
Takushi
Nomura
[NIID] |
Broadening of
CD8+ T-cell targets precedes accumulation of proviral escape mutations
in SIV controllers |
| P-26 |
Tomohiro
Akahoshi
[Kumamoto Univ.] |
Conflicting viral
selection by HIV-1-specific CTLs |
| P-27 |
Nozomi
Kuse
[Kumamoto Univ.] |
Long-term control
of HIV-1 by two cross-reactive HLA-B*51:01-restricted CTLs |
| P-28
O-3A-21 |
Takayuki
Chikata
[Kumamoto Univ.] |
The impact of
amino-acid substitution at a position outside the peptide binding
groove of HLA-C subtypes in HIV-1-specific T cell recognition |
| P-29 |
Xiaoming
Sun
[Kumamoto Univ.] |
Analysis of non-canonical
Vδ-Vβ TCRs in HIV-1 specific CTLs |
| P-30
O-3A-22 |
Zhansong
Lin
[Kumamoto Univ.] |
The effect of
co-expression of KIRs and their HLA ligands on HIV-1 control |
| P-31 |
Tran
Van Giang
[Kumamoto Univ.] |
Identification
of HLA-associated HIV-1subtype A/E polymorphism in a Vietnamese cohort |
| P-32
O-3A-19 |
Hayato
Murakoshi
[Kumamoto Univ.] |
Effective control
of HIV-1 by cytotoxic T cells specific for multiple conserved epitopes |
| P-33 |
Mohammad
Arif Rahman
[Kumamoto Univ.] |
Effect of NNRTI-resistance
Y181C/V/I mutations on HIV-1-specific CTL recognition in subtype B
and the subtype A/E infections |
| P-34 |
Bin Liu
[Nankai Univ., China] |
Subtypes, CTL
epitope variation and silencing by a broad-spectrum short hairpin
RNA of HIV-1 gag gene from epidemic strains among men who have sex
with men (MSM) in Tianjin, China |
| P-35 |
Mako
Toyoda
[Kumamoto Univ.] |
Differential
modulation of Nef-mediated down-regulation of viral entry receptors
is mediated by multiple sequence motifs in HIV-1 elite controllers. |
| P-36
O-3A-20 |
Macdonald
Mahiti
[Kumamoto Univ.] |
Natural isolated
HIV-1 Nef differentially recognize the cytoplasmic tails of HLA-A
and HLA-B molecules for down-regulation |
| P-37 |
Stanley
C. Meribe
[Kumamoto Univ.] |
Functional characterization
of a deleterious naturally-arising HIV-1 Nef polymorphism Ile-20 |
| P-38 |
Doreen
Kamori
[Kumamoto Univ.] |
Effects of natural
variability of an immunodominant Vpr region on immunological footprints
and protein functions. |
| P-39 |
Francis
Mwimanzi
[Kumamoto Univ.] |
Establishment
of simultaneous assessment of HIV-1 Nef-mediated down-regulation of
cell surface HLA-A and HLA-B molecules |
| P-40 |
Takeshi
Nishijima
[NCGM/ Kumamoto Univ.] |
Is routine ophthalmologic
screening useful in care of patients with HIV-1 infection? |
| P-41
O-3B-28 |
Daisuke
Mizushima
[NCGM/ Kumamoto Univ.] |
Prognosis of
renal function of Vietnamese HIV-infected patients with mild-to-moderate
renal dysfunction on tenofovir |
| P-42
O-3B-32 |
Yasuaki
Yanagawa
[NCGM/ Kumamoto Univ.] |
Long-term Prognosis
for HIV Associated Kaposi’s Sarcoma In the Era of cART in Japan |
| P-43
O-3B-34 |
Sarah
Ameen Almofty
[Kumamoto Univ.] |
A TREX-2 component
GANP is dispersed from the nuclear envelope during HIV-1 virus entry
and associated with integrase in the host cell nucleus |
| P-44
O-3B-35 |
Mayuko
Shimoda
[Kumamoto Univ.] |
GANP that interacts
with HIV-1 integrase inherently suppresses retrotransposition |
| P-45
O-3B-33 |
Ekram
W. Abd El- Wahab
[Kumamoto Univ.] |
Specific Recognition
of the HIV-1 genomic RNA by the Gag precursor |
| P-46 |
Xiaomei
T. Kuang
[Simon Fraser Univ., Canada] |
Examining HIV-1
Epitope Presentation in the Presence of HDAC inhibitors |